Effektivnost' kombinirovannykh preparatov v terapii ostrykh vospalitel'nykh zabolevaniy LOR-organov

The high prevalence of acute respiratory infections (ARI) and the extremely low efficiency of prevention are largely attributable to the variety of etiologically significant pathogens. The main direction of causal treatment of ARVI includes the use of antiviral drugs. Along with this, combined drugs are widely used in the treatment of patients with SARS; the components of combined drugs affect the basic symptoms and pathogenetic mechanisms of respiratory viral infections. This group of drugs includes Caffetin Cold, which is composed of paracetamol, pseudoephedrine hydrochloride, dextromethorphan hydrobromide, and ascorbic acid. In general, the components of the drug Caffetin Cold, acting on the leading symptoms of ARVI, provide a vasoconstrictor, anti-inflammatory and antitussive effects. In this connection, application of Caffetin Cold at the early stages and/or in mild disease contributes to the regression of the symptoms of acute respiratory disease, and improvement of subjective feelings of patients.

acute respiratory viral infections, inflammatory diseases of ENT organs, non-steroidal anti-inflammatory drugs, Caffetin Cold